Zillion partners with Dexcom on continuous glucose monitoring (CGM) data
Zillion has announced a partnership with Dexcom, a leading provider of real-time continuous glucose monitoring (CGM), to connect Dexcom CGM with Zillion’s platform for use
Zillion has announced a partnership with Dexcom, a leading provider of real-time continuous glucose monitoring (CGM), to connect Dexcom CGM with Zillion’s platform for use
After receiving an FDA green light for the project earlier this year, Dexcom is now making its diabetes data available through consumer electronic devices. Leading
One Drop has announced outcomes from a study on the effects of the AI-powered blood glucose (BG) forecasting feature of its One Drop digital health
Sanofi and Roche have joined forces in France to drive adoption of a connected add-on for disposable insulin pens. The partners will jointly develop a
A set of policy recommendations have been drafted by the European Diabetes Forum (EUDF), emphasising the importance of digitalisation, data registries and integrated care to
Following new guidelines from the National Institute for Care and Excellence (NICE) which recommends that adults with Type 1 diabetes should be offered a choice
As reported in August 2022 by MedTechDive,The Omnipod 5 is one of two insulin pumps manufactured by the company that can be purchased through pharmacies,
Diabetic neuropathy is a form of nerve damage that may occur in people with diabetes, linked to heightened blood sugar levels. It most commonly affects
After decades of having to juggle multiple devices and fingerprick systems to take their own blood sugar readings and use them to calculate insulin dosages,
All 130,000 Australians with Type 1 diabetes will now get access to subsidised continuous glucose monitoring (CGM) devices under the newly-elected Australian Prime Minister Anthony